Enliven Therapeutics, Inc. ($ELVN)
Filing Information
| Accession Number | 0000947871-26-000653 |
|---|---|
| Form Type | 4 |
| Filing Date | Jun 24, 2026 |
| Document | View SEC Filing |
Transactions
4
Total Shares
860,123
Total Value
$39,014,045.60
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
10% Owner | Common Stock | โ | Jun 22, 2026 | Sale | 24,846 | $45.38 | $1,127,511.48 | 220,882 | Indirect | See Footnotes | View Details | |
10% Owner | Common Stock | โ | Jun 22, 2026 | Sale | 1,477 | $45.00 | $66,465.00 | 219,405 | Indirect | See Footnotes | View Details | |
10% Owner | Common Stock | โ | Jun 22, 2026 | Sale | 787,024 | $45.38 | $35,715,149.12 | 6,601,878 | Indirect | See Footnotes | View Details | |
10% Owner | Common Stock | โ | Jun 22, 2026 | Sale | 46,776 | $45.00 | $2,104,920.00 | 6,555,102 | Indirect | See Footnotes | View Details |